about
Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitroThe Extracellular Matrix in Bronchopulmonary Dysplasia: Target and SourceRoles for β-catenin and doxycycline in the regulation of respiratory epithelial cell frequency and functionHospital acquired pneumonia with high-risk bacteria is associated with increased pulmonary matrix metalloproteinase activityA self-propagating matrix metalloprotease-9 (MMP-9) dependent cycle of chronic neutrophilic inflammation.alpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer.Serum biomarker analysis of collagen disease patients with acute-onset diffuse interstitial lung disease.Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study.Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells.The PPARγ agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthmaDexamethasone ameliorates H₂S-induced acute lung injury by alleviating matrix metalloproteinase-2 and -9 expressionDifferential expression of MMP-2 and -9 and their inhibitors in fetal lung cells exposed to mechanical stretch: regulation by IL-10.Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.Matrix metalloproteinase-2 and -9 activities in the human lens epithelial cells and serum of steroid induced posterior subcapsular cataracts.In vitro cytotoxicity and mutagenicity of mainstream waterpipe smoke and its functional consequences on alveolar type II derived cells.Depletion of Neutrophils Promotes the Resolution of Pulmonary Inflammation and Fibrosis in Mice Infected with Paracoccidioides brasiliensis.Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model.Metalloproteinases and their inhibitors are influenced by inhalative glucocorticoid therapy in combination with environmental dust reduction in equine recurrent airway obstructionThe role of selenium, zinc and antioxidant vitamin supplementation in the treatment of bronchial asthma: adjuvant therapy or not?Low levels of tissue inhibitor of metalloproteinase-2 at birth may be associated with subsequent development of bronchopulmonary dysplasia in preterm infantsExpressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases.Matrix metalloproteases: underutilized targets for drug deliveryTransgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in miceTransgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice.Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.The a"MAZE"ing world of lung-specific transgenic mice.Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.Correlation of matrix metalloproteinase-2 and -9 expression with recurrences in primary spontaneous pneumothorax patients.ACE2, a promising therapeutic target for pulmonary hypertension.Inflammatory effects of inhaled sulfur mustard in rat lungFibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells.Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects.Respiratory effects of sulfur mustard exposure, similarities and differences with asthma and COPD.Knockdown of MMP12 inhibits the growth and invasion of lung adenocarcinoma cells.Combination of Sasa quelpaertensis Nakai leaf extract and cisplatin suppresses the cancer stemness and invasion of human lung cancer cells.Aryl hydrocarbon receptor (AhR) agonists increase airway epithelial matrix metalloproteinase activity.Inflammation and lung injury in an ovine model of extracorporeal membrane oxygenation support.Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival.Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways.Diallyl sulfide, diallyl disulfide, and diallyl trisulfide inhibit migration and invasion in human colon cancer colo 205 cells through the inhibition of matrix metalloproteinase-2, -7, and -9 expressions.
P2860
Q24799057-B7E2B395-8C25-4C39-8335-223F64F67252Q26771338-23CA5023-9C31-4F66-BF67-28B4881C1D80Q28395832-4302BA17-9275-4CD5-AB2B-8F37E43B885DQ33359741-8794A293-B7D9-4FDC-8633-DA7A63AEB704Q33797926-4FA42DDA-9387-40BE-B436-7A9B9DB9EC27Q34357105-B75C85B2-24AB-411A-8318-575044962ECFQ34584869-8A413F35-307B-460A-A54C-BBE66CDC2EB0Q34924313-36B7C515-5701-4EE6-93F8-CC8F4749B28DQ35065126-4B3C4F9A-B39E-4B83-B729-358A78822CAAQ35080151-B59602FD-8795-4238-96E3-ABA580ECC8DDQ35145163-A9AB8EB0-B262-464A-AB11-8713747BB9C3Q35360761-ACF98E20-820A-4651-970A-F7D394369BA8Q35553707-C3436AF3-6EE7-4F3A-BDB0-AF29B35A4F6AQ35677331-8652BC55-32E9-4D59-A8BE-4FE8FF9E1DE7Q36124806-45A57762-95AB-46BF-BA2A-40A539D50A87Q36149864-A7496186-C364-4B92-9EB9-43F7C750C72FQ36203143-AB74FDF9-0B1F-4B53-803B-72778F82EFAFQ36219151-7CC0C6A6-D4C8-4C87-A444-155861744F7CQ36249896-93DD1E09-0988-413E-869C-0BC753794F2FQ36363652-6E6BB1FE-E319-426D-9AEF-F0E8A43EDECEQ36681389-12CF7D7F-ED16-45BA-BA87-13905E5785A5Q36761849-038D7A4C-F0B1-4483-AEEA-320FC953D7F7Q37100760-BABB0D90-DE69-46F0-9C76-F32DA4AF0BF5Q37100777-C3566298-86C7-400B-9A5E-8B8730A00283Q37115894-D93ABAA2-D92E-42A4-9611-D0DD8948DECDQ37202364-BE71A1D4-F823-4724-9531-8E4DD9AB0480Q37360395-7525906B-1DD6-4FB3-A041-96EB79C2157FQ37581268-B19272A8-D82A-467E-A719-E3990ACE756DQ37826865-07E953E6-2CE6-4311-AEB7-482FE4DAD7C8Q38272756-381940AB-2390-482C-AC5B-EC27E2C0BE58Q38311007-C8B6B378-E7EC-4470-AB97-EE36F3548C36Q38371167-75F97777-01C7-4366-A5B9-52320FA90CB3Q38658788-8E1A60C2-747D-4F8F-A693-377AF83C5211Q38894139-8FFFC0C6-5DDB-486F-BA50-908BC98F26DFQ38994079-4BC0830F-E754-48FE-836B-7129FFDD2ADBQ39029928-D6BD260A-DF02-4FD2-97FF-B4B1EEBA8FFEQ39213893-6F7D8119-ED9C-43AF-AAD4-290FE3C6CBC2Q39412611-7F9B42D0-9D99-4CF0-BA76-45B3C920387DQ39465565-2362F9E3-5E31-4839-8BC4-296EBE209F24Q39520212-B024E769-014C-4624-9022-CF9377F00F9D
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Matrix metalloproteinases in lung diseases.
@ast
Matrix metalloproteinases in lung diseases.
@en
Matrix metalloproteinases in lung diseases.
@nl
type
label
Matrix metalloproteinases in lung diseases.
@ast
Matrix metalloproteinases in lung diseases.
@en
Matrix metalloproteinases in lung diseases.
@nl
prefLabel
Matrix metalloproteinases in lung diseases.
@ast
Matrix metalloproteinases in lung diseases.
@en
Matrix metalloproteinases in lung diseases.
@nl
P356
P1476
Matrix metalloproteinases in lung diseases.
@en
P2093
Hiroyuki Ohbayashi
P304
P356
10.2174/1389203023380549
P577
2002-08-01T00:00:00Z